I posted this earlier tonight and would appreciate comments.Their is ongoing research at different Institutes and reseach facilities using skin cells and reprograming them into brain cells.The patents Fibrocell hold and are exclusive in growing skin cell (Fibroblasts) technology which these labs need to licence to grow these cells on a wider range for injecting on a larger scale for ALZHEIMERS disease and other disorders in the brain cavity to transmit signals from cells to neurons in these patients.One of the Institutes are making great progress in this research and you can read about their progress at (http://www.upi.com) just enter skin cells in the article area and go to the left page and click on SKIN CELLS TURNED INTO BRAIN CELLS ARTICLE.Other research is ongoing for using skin cells for Muscles and even that involving the Heart.When I spoke with Public Relations I talked about this topic with her and she stated they are aware of this as they could licence out their technology as long as the end result don't interfere with the dermatology aspect of Fibrocells business.After spending $175 Million on this technology one would believe this technology is at least worth that figure and that would equate to about $1.20 per share.Safe money as I now believe the investors that just in $23 Million a few weeks ago knew this was a option and the technology is very valuable.This is all patented technology for many years to come.Cell science is the near and distant future for medicine as we all are aware of at this point.
In an article in the journal Cell Stem Cell, Sheng Ding, a scientist at the Gladstone Institutes in San Francisco, reported on a way of transforming adult skin cells into neurons that are capable of transmitting brain signals, a Gladstone release reported Thursday.
"This work could have important ramifications for patients and families who suffer at the hands of neurodegenerative diseases such Alzheimer's, Parkinson's and Huntington's disease," Lennart Mucke, director of neurological research at Gladstone, said.
There ya go Spliffy, they make have the cure for stupidity and old age all wrapped up in one shot~!
Love ya so much Spliffy~!
Dude, will you please quit the senseless pumping of B/S you yourself don't even understand.
Your desperation is so obvious. Earnings move stocks, not "pie in the sky" trump up fiction.
Talk to us about the "dilution effect" of the recent financing and how it reduced the value of the stock and the value of all invested capital.
So stick to stuff related to the "bottom line" and cut the "cow dung" because we ain't buying it pal.
Talking with other investors via email I understand you have been short on FCSC for a long time.You were wrong about them not going to be FDA approved and wrong again on obtaining financing recently.With that in mind your opinion dont matter on this subject as this was intended for investors not shorters of the company stock.Earnings do move stocks is however correct as you say and their Q2 coming any day will move the price upward as it will be much better than Q1 as they had spent many Millions less as it's FDA approved with not much associated costs being reported for Q2.
I just can't believe that for a minute.Dont think most investors know the value but then again the financing will be closing on Thursday this week.Should be increasing faster than it currently has in the past.The .57 is a very cheap price.